110 related articles for article (PubMed ID: 15568633)
1. [Long acting insulin analogs: possibly more stable glucose regulation].
van der Wal PS; van de Kraats GB
Ned Tijdschr Geneeskd; 2004 Nov; 148(45):2248. PubMed ID: 15568633
[No Abstract] [Full Text] [Related]
2. [Long-acting insulin analogs: progressing slowly].
Geelhoed-Duijvestijn PH
Ned Tijdschr Geneeskd; 2004 Nov; 148(45):2248; author reply 2248-9. PubMed ID: 15568634
[No Abstract] [Full Text] [Related]
3. [A new long-acting insulin analog. "Fewer hypoglycemias observed"].
Gallwitz B
MMW Fortschr Med; 2004 Jan; 146(3-4):47. PubMed ID: 15035450
[No Abstract] [Full Text] [Related]
4. [Delayed action insulins. What is the value of insulin glargine in general practice?].
MMW Fortschr Med; 2001 Apr; 143(16):54-6. PubMed ID: 11367996
[No Abstract] [Full Text] [Related]
5. Insulin detemir (levemir), a new long-acting insulin.
Med Lett Drugs Ther; 2006 Jul; 48(1238):54-5. PubMed ID: 16841022
[TBL] [Abstract][Full Text] [Related]
6. [Novo Nordisk introduces a new basic insulin for marketing].
Krankenpfl J; 2004; 42(5-6):168-9. PubMed ID: 15527230
[No Abstract] [Full Text] [Related]
7. [Use of semisynthetic human insulins in diabetes mellitus].
Nedosugova LV; Balabolkin MI; Tsaguriia KG
Sov Med; 1991; (10):75-8. PubMed ID: 1801244
[No Abstract] [Full Text] [Related]
8. [Economics under scrutiny - experts discuss long acting insulin analogs].
Pflege Z; 2011 Jan; 64(1):58. PubMed ID: 21305792
[No Abstract] [Full Text] [Related]
9. An update on the long-acting insulin analogue glargine.
Thisted H; Johnsen SP; Rungby J
Basic Clin Pharmacol Toxicol; 2006 Jul; 99(1):1-11. PubMed ID: 16867163
[TBL] [Abstract][Full Text] [Related]
10. Insulin detemir: new drug. A second long-acting insulin analogue: many uncertainties, few advantages.
Prescrire Int; 2006 Oct; 15(85):163-7. PubMed ID: 17121210
[TBL] [Abstract][Full Text] [Related]
11. [Widened indications. More latitude with insulin analogs].
MMW Fortschr Med; 2003 Sep; 145(39):52. PubMed ID: 14649078
[No Abstract] [Full Text] [Related]
12. Insulin aspart: a review.
Owens D; Vora J
Expert Opin Drug Metab Toxicol; 2006 Oct; 2(5):793-804. PubMed ID: 17014395
[TBL] [Abstract][Full Text] [Related]
13. Insuline glusine (Apidra): a new rapid-acting insulin.
Med Lett Drugs Ther; 2006 Apr; 48(1233):33-4. PubMed ID: 16625142
[TBL] [Abstract][Full Text] [Related]
14. Premixed biphasic insulin analogs - a choice for pediatric patients with type 2 diabetes rather than type 1 diabetes?
Danne T
Pediatr Diabetes; 2006 Feb; 7(1):1-3. PubMed ID: 16489967
[No Abstract] [Full Text] [Related]
15. 2008 resource guide. Insulin. Along with human insulin analogs, recombinant DNA human insulins are the most widely used insulins in this country. Through genetic engineering, bacteria or yeast are transformed into little "factories" that produce synthetic human insulin.
Diabetes Forecast; 2008 Jan; 61(1):RG11-4. PubMed ID: 18290288
[No Abstract] [Full Text] [Related]
16. Determining effective insulin analog therapy based on the individualized needs of patients with type 2 diabetes mellitus.
Gong WC
Pharmacotherapy; 2008 Oct; 28(10):1299-308. PubMed ID: 18823224
[TBL] [Abstract][Full Text] [Related]
17. [Combinations of insulin preparations: one or the other].
van der Meer J
Ned Tijdschr Geneeskd; 1986 Jun; 130(24):1092-4. PubMed ID: 3523262
[No Abstract] [Full Text] [Related]
18. Cost-effectiveness of insulin analogs.
Brixner DI; McAdam-Marx C
Am J Manag Care; 2008 Nov; 14(11):766-75. PubMed ID: 18999911
[TBL] [Abstract][Full Text] [Related]
19. [Update on new insulins].
Tapia Ceballos L
An Pediatr (Barc); 2009 Jan; 70(1):65-71. PubMed ID: 19174123
[TBL] [Abstract][Full Text] [Related]
20. Intensive insulin therapy and insulin pumps.
Bode BW
Postgrad Med; 2002 Nov; 112(5 Suppl Designer):17-21. PubMed ID: 19667601
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
